HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David A. Fullerton James D. Albert Michael R. Johnston Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robinson, R. D. Articles by Johnston, M. R. Search for Related Content PubMed PubMed Citation Articles by Robinson, R. D. Articles by Johnston, M. R.

Ann Thorac Surg 1994;57:286-288
© 1994 The Society of Thoracic Surgeons

---

Articles

Use of pleural tenckhoff catheter to palliate malignant pleural effusion

^a Department of Surgery, University of Colorado Health Sciences Center, Denver, Colorado, USA
^b Division of Thoracic Surgery, University of Toronto, Toronto, Ontario, Canada

^_* Address reprint requests to Dr Fullerton, Department of Surgery, Campus Box C-310, University of Colorado Health Science Ctr, Denver, CO 80262.

Malignant pleural effusion and its treatment both cause substantial morbidity in patients with advanced neoplastic disease. We hypothesized that this morbidity might be ameliorated by placement of an indwelling Tenckhoff catheter into the involved pleural space. Catheters were placed in 9 patients under local anesthesia. Three patients underwent bilateral catheter placement, for a total of 12 catheters placed. Four of the 9 patients had undergone previous unsuccessful pleurodesis (using tetracycline or bleomycin). Whenever it became symptomatic, the malignant pleural effusion was simply drained into a calibrated container and the volume recorded. Patients were followed on a weekly basis until their death (mean, 16 weeks). The mean drainage was 477 mL per 24 hours (range, 200 to 1,100 mL). No pleural space infections occurred, although local cellulitis developed in 3 patients around the catheter exit site; all patients responded to oral antibiotics. There were no significant changes in either the serum albumin or total protein levels. No catheters malfunctioned and no patients required further treatment or hospitalization for symptoms of malignant pleural effusion. We conclude that this technique may reduce the morbidity stemming from malignant pleural effusion and its treatment by allowing patients to conveniently and painlessly drain the effusion at home when it becomes symptomatic. This technique may provide superior palliation in patients with malignant pleural effusion.

This article has been cited by other articles:

				R. A Qureshi, S. L Collinson, R. J Powell, P. O Froeschle, and R. G Berrisford Management of Malignant Pleural Effusion Associated with Trapped Lung Syndrome Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 120 - 123. [Abstract] [Full Text] [PDF]

				W. H. Warren, A. W. Kim, and M. J. Liptay Identification of clinical factors predicting Pleurx(R) catheter removal in patients treated for malignant pleural effusion Eur J Cardiothorac Surg, January 1, 2008; 33(1): 89 - 94. [Abstract] [Full Text] [PDF]

				P. Rousseau Malignant pleural effusions: A brief synopsis American Journal of Hospice and Palliative Medicine, November 1, 1997; 14(6): 302 - 304. [PDF]